These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 1800944)

  • 41. Opiate withdrawal signs precipitated by naloxone following a single exposure to morphine: potentiation with a second morphine exposure.
    Schulteis G; Heyser CJ; Koob GF
    Psychopharmacology (Berl); 1997 Jan; 129(1):56-65. PubMed ID: 9122364
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of peripheral and central administration of calcium channel blockers in the naloxone-precipitated abstinence syndrome in morphine-dependent rats.
    Baeyens JM; Esposito E; Ossowska G; Samanin R
    Eur J Pharmacol; 1987 May; 137(1):9-13. PubMed ID: 3609136
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects induced by BC 264, a selective agonist of CCK-B receptors, on morphine-dependent rats.
    Maldonado R; Valverde O; Derrien M; Tejedor-Real P; Roques BP
    Pharmacol Biochem Behav; 1994 Jun; 48(2):363-9. PubMed ID: 8090802
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evidence that 5-hydroxytryptamine in the forebrain is involved in naloxone-precipitated jumping in morphine-dependent rats.
    Cervo L; Romandini S; Samanin R
    Br J Pharmacol; 1983 Aug; 79(4):993-6. PubMed ID: 6686075
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mianserin attenuates naloxone-precipitated withdrawal signs in rats acutely or chronically dependent upon morphine.
    Neal BS; Sparber SB
    J Pharmacol Exp Ther; 1986 Jan; 236(1):157-65. PubMed ID: 3001281
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cerebrospinal fluid from morphine-dependent rats precipitates opiate abstinence syndrome.
    Malin DH; Harter L; Jenkins PD; Monfort RD; Bruce PD; Farley PA; Ferebee R; Thrasher KL; Marullo DS
    Life Sci; 1987 Jul; 41(3):377-83. PubMed ID: 3600184
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neuropeptide FF (NPFF) reduces the expression of morphine- but not of ethanol-induced conditioned place preference in rats.
    Kotlinska J; Pachuta A; Dylag T; Silberring J
    Peptides; 2007 Nov; 28(11):2235-42. PubMed ID: 17884254
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ontogeny of neuropeptide FF pharmacology and receptors in mouse brain.
    Desprat C; Zajac JM
    Brain Res Dev Brain Res; 1994 Oct; 82(1-2):118-26. PubMed ID: 7842499
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Oxytocin neurone autoexcitation during morphine withdrawal in anaesthetized rats.
    Brown CH; Munro G; Johnstone LE; Robson AC; Landgraf R; Russell JA
    Neuroreport; 1997 Mar; 8(4):951-5. PubMed ID: 9141071
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sites of action of morphine involved in the development of physical dependence in rats. I. Comparison of precipitated morphine withdrawal after intraperitoneal and intraventricular injection of morphine antagonists.
    Laschka E; Herz A; Bläsig J
    Psychopharmacologia; 1976 Mar; 46(2):133-9. PubMed ID: 986051
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antisense oligonucleotides to human SQA-neuropeptide FF decrease morphine tolerance and dependence in mice.
    Gelot A; Francés B; Gicquel S; Zajac JM
    Eur J Pharmacol; 1998 Oct; 358(3):203-6. PubMed ID: 9822885
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neural correlates of the motivational and somatic components of naloxone-precipitated morphine withdrawal.
    Frenois F; Cador M; Caillé S; Stinus L; Le Moine C
    Eur J Neurosci; 2002 Oct; 16(7):1377-89. PubMed ID: 12405997
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Acute opioid physical dependence in humans: effect of naloxone at 6 and 24 hours postmorphine.
    Heishman SJ; Stitzer ML; Bigelow GE; Liebson IA
    Pharmacol Biochem Behav; 1990 Jun; 36(2):393-9. PubMed ID: 2356213
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Relative involvement of supraspinal and spinal mu opioid receptors in morphine dependence in mice.
    Miyamoto Y; Takemori AE
    Life Sci; 1993; 52(12):1039-44. PubMed ID: 8383266
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of opioid receptors in the spinal antinociceptive effects of neuropeptide FF analogues.
    Gouardères C; Jhamandas K; Sutak M; Zajac JM
    Br J Pharmacol; 1996 Feb; 117(3):493-501. PubMed ID: 8821539
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Morphine dependence is associated with changes in neuropeptide S receptor expression and function in rat brain.
    Ghazal P; Ciccocioppo R; Ubaldi M
    Peptides; 2013 Aug; 46():6-12. PubMed ID: 23684726
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Alteration of morphine withdrawal to naloxone by interferon.
    Dafny N; Zielinksi M; Reyes-Vazquez C
    Neuropeptides; 1983 Oct; 3(6):453-63. PubMed ID: 6420721
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of spinal and supraspinal muscarinic receptors in the expression of morphine withdrawal symptoms in the rat.
    Holland LN; Shuster LC; Buccafusco JJ
    Neuropharmacology; 1993 Dec; 32(12):1387-95. PubMed ID: 8152529
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Precipitation and prevention of abstinence in acutely morphinized rats and mice: comparisons between naloxone, naltrexone, and diprenorphine (author's transl)].
    Tremblay E; Colombel MC; Jacob J
    Psychopharmacology (Berl); 1976 Aug; 49(1):41-8. PubMed ID: 822446
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Focal kappa-opioid receptor-mediated dependence and withdrawal in the nucleus paragigantocellularis.
    Sinchaisuk S; Ho IK; Rockhold RW
    Pharmacol Biochem Behav; 2002 Dec; 74(1):241-52. PubMed ID: 12376173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.